EPFL spin-off GTX medical moves into the US market

EPFL spin-off GTX medical moves into the US market

22.10.2019 GTX medical, an EPFL spin-off that has developed an implantable neuromodulation therapy to help people with spinal cord injuries walk again, merged today with NeuroRecovery Technologies, a US-based company, developing a transcutaneous stimulation therapy to improve upper limb function after a SCI. The combined entity, which retains the name GTX medical, is set to become the global leader in its niche.

Read more in EPFL News